Macrolide Antibiotics Market Sales to Reach USD 146,979.68 Million by 2029


Macrolide Antibiotics Market refer to a class of antibiotics derived from Saccharopolyspora erythraea and inhibit protein synthesis in bacteria by binding to the 50S ribosomal element. These antibiotics are effective against gram positive bacteria and intracellular pathogens, such as Chlamydia and Mycoplasma and legionella.

Global Macrolide Antibiotics Market was valued at USD 55,287.85 Million in 2021 and is projected to reach USD 146,979.68 Million by 2029, registering a CAGR of 13.00% during the forecast period 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, price analysis, and regulatory framework.

Get a sample PDF of the report –

Macrolide Antibiotics Market Dynamics

This section deals with understanding the market drivers, benefits, opportunities, restraints, and challenges. All this is discussed in detail as below:

The rapid expansion of antibiotics owing to the increasing burden of infectious diseases across the globe is one of the major drivers for the growth of the macrolide antibiotics market.

  • Prevalence of skin infections

Rising prevalence of skin infections, such as cellulitis, erysipelas, and impetigo, among the population is accelerating the growth of the market.

The large increase in investment in the form of funds and subsidies for antibiotics is further influencing the growth of the market.


Additionally, product innovations provide profitable opportunities for market players during the forecast period of 2022 to 2029. Additionally, supportive government policies will further expand the macrolide antibiotics market.

Global Macrolide Antibiotics Market Scope and Market Size

The macrolide antibiotics market is segmented on the basis of drug, route of administration, infection, and end user. The growth among these segments will help you analyze weak growth segments in the industries and provide users with valuable market insight and market insights to help them make strategic decisions to identify major applications of the market.


  • Azithromycin
  • Clarithromycin
  • Erythromycin
  • Fidaxomicin
  • Telithromycin

On the basis of drugs, the macrolide antibiotics market has been segmented into azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin.

Route of administration

On the basis of route of administration, the macrolide antibiotic market has been segmented into oral and parenteral administration.


  • Mycoplasma pneumoniae
  • Legionella sp.
  • Bordetella whooping cough
  • Symptomatic cat scratch disease
  • Bacillary angiomatosis
  • Pelioshepatis
  • Cerebral toxoplasmosis
  • Uncomplicated skin infections

Based on infectionmacrolide antibiotics market is segmented into mycoplasma pneumoniae, legionella sp., bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, pelioshepatis, cerebral toxoplasmosis, and uncomplicated skin infections.

Final user

  • Hospital
  • Dermatology clinic
  • Clinical
  • Ambulatory Center
  • Research laboratories

On the basis of end-user, the macrolide antibiotics market is segmented into hospital, dermatology clinic, clinic, ambulatory center and research laboratories.

To learn more about the research methodology, submit a request to speak to our industry experts

Regional Analysis/Overview of the Macrolide Antibiotics Market

Macrolide Antibiotics market is analyzed and market size insights and trends are provided by country, drug, route of administration, infection and end-user as listed above. The countries covered in the Macrolide Antibiotics market report are USA, Canada & Mexico North America, Germany, France, UK, Netherlands, Switzerland, Belgium , Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan and India. , South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of ‘South America.

North America dominates the macrolide antibiotics market owing to the increasing prevalence of bacterial skin infections in the region. Asia-Pacific (APAC) is expected to experience significant growth during the forecast period of 2022 to 2029 owing to the growing awareness of the use of macrolides for the treatment of uncomplicated skin infections in the region.

The country section of the report also provides individual market impacting factors and regulatory changes in the national market that impact current and future market trends. Data points such as upstream and downstream value chain analysis, technical trends and bearer five forces analysis, case studies are some of the indicators used to forecast the market scenario for each country. In addition, the presence and availability of global brands and the challenges they face due to significant or rare competition from local and national brands, the impact of domestic tariffs and trade routes are considered while providing a forecast analysis of national data.

Competitive landscape and Macrolide Antibiotics Market Share Analysis

Macrolide Antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, research and development investment, new market initiatives, global presence, locations and production facilities, production capacities, company strengths and weaknesses, product launch, product breadth and breadth, application dominance. The data points above provided are only related to the focus of the companies in the macrolide antibiotics market.

Some of the major players operating in the macrolide antibiotics market are GlaxoSmithKline plc. (USA), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Lily. (USA), Pfizer Inc. (USA), Merck & Co., Inc. (USA), Bristol-Myers Squibb Company (USA), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Boehringer Ingelheim International Gmbh (Germany), Sanofi (France), Astrazeneca (UK), AbbVie Inc. (USA), Abbott (USA), Bayer AG (Germany) ), Sandoz International GmbH (Germany), Johnson & Johnson Services, Inc. (USA), Zhejiang Guobang Pharmaceutical Co., Ltd. (China) and Barkat Pharmaceutical Group (Iran), among others.

Browse the full table of contents at

Related reports:

North America compression therapy market– Industry size, shares, trends and growth prospects

Compression therapy market in Europe– Industry size, shares, trends and growth prospects

Asia Pacific Compression Therapy Market – Industry size, shares, trends and growth prospects

Cold Compression Therapy Market– Industry size, shares, trends and growth prospects

Capillary Blood Collection Devices Market – Industry size, shares, trends and growth prospects

Venous Blood Collection Devices Market– Industry size, shares, trends and growth prospects

Laser Doppler Blood Flow Measurement Devices Market – Industry size, shares, trends and growth prospects

About Data Bridge Market Research:

One absolute way to predict what the future holds is to understand today’s trend!

Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting company with an unparalleled level of resilience and integrated approaches. We are committed to unearthing the best market opportunities and fostering effective information for your business to thrive in the market. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a suite of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has over 500 analysts working across different industries. We have served over 40% of Fortune 500 companies globally and have a network of over 5,000 clients worldwide. Data Bridge is expert in creating satisfied customers who rely on our services and rely on our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact us:-

Data Bridge Market Research

USA: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

E-mail:- [email protected]


About Author

Comments are closed.